StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Exicure's profit margin for the twelve months ending Dec 31, 2024 was -1940.2%. For fiscal 2024 it was -1940.2%, against -9.0% the year before. The highest annual figure on record is -9.0% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-1940.2%−1931.2
FY2022Dec 31, 2022-9.0%+139.5
FY2020Dec 31, 2020-148.5%+1881.1
FY2019Dec 31, 2019-2029.6%+16964.5
FY2018Dec 31, 2018-18994.1%−18880.8
FY2017Dec 31, 2017-113.3%+1521.9
FY2016Dec 31, 2016-1635.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-165.8%+159.7
Q4 FY2022Dec 31, 202284.5%+737.2
Q3 FY2022Sep 30, 2022-256.0%+17806.1
Q2 FY2022Jun 30, 2022-302.3%+949.1
Q1 FY2022Mar 31, 2022-325.5%+8735.3
Q4 FY2021Dec 31, 2021-652.7%−291.6
Q2 FY2021Jun 30, 2021-18062.0%−17973.1
Q1 FY2021Mar 31, 2021-1251.5%−1264.0
Q4 FY2020Dec 31, 2020-9060.7%−5841.0
Q3 FY2020Sep 30, 2020-361.1%+742.5
Q2 FY2020Jun 30, 2020-88.9%+1113.8
Q1 FY2020Mar 31, 202012.5%+21156.5
Q4 FY2019Dec 31, 2019-3219.7%+76030.3
Q3 FY2019Sep 30, 2019-1103.6%+8236.7
Q2 FY2019Jun 30, 2019-1202.8%+34718.3
Q1 FY2019Mar 31, 2019-21144.0%−5841.2
Q4 FY2018Dec 31, 2018-79250.0%−79085.7
Q3 FY2018Sep 30, 2018-9340.4%−8522.7
Q2 FY2018Jun 30, 2018-35921.1%–
Q1 FY2018Mar 31, 2018-15302.8%–
Q4 FY2017Dec 31, 2017-164.3%–
Q4 FY2016Dec 31, 2016-817.7%–

More Exicure figures

See a number that looks wrong?